MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

MeiraGTx (Nasdaq: MGTX) announced that the Compensation Committee of its Board approved equity awards under the 2026 Employment Inducement Award Plan for a new employee, in accordance with Nasdaq Listing Rule 5635(c)(4). The grant includes 75,000 non-qualified stock options and 75,000 time-based RSUs.

The stock options have an exercise price equal to the closing price of MeiraGTx ordinary shares on the employee’s start date. Twenty‑five percent of the options vest on the first anniversary, with the remainder vesting in 36 substantially equal monthly installments, subject to continued employment. For the RSUs, 50% vest on the second anniversary, and 25% on each of the third and fourth anniversaries, also contingent on continued employment.

Market Context

The prior inducement-grant event, news_id 1058097, recorded a -5.53% 24-hour reaction. That preceden...

Analysis

The prior inducement-grant event, news_id 1058097, recorded a -5.53% 24-hour reaction. That precedent frames this award as an equity-compensation event; recent Net Selling insider activity is a risk factor to monitor.

Key Figures

Stock options: 75,000 shares Initial option vesting: 25% Remaining option vesting: 36 installments +4 more

7 metrics

Stock options 75,000 shares Inducement equity award

Initial option vesting 25% First anniversary of employee start date

Remaining option vesting 36 installments Monthly installments after first anniversary

Restricted stock units 75,000 RSUs Time-based inducement award

Second-anniversary RSU vesting 50% RSU vesting schedule

Third-anniversary RSU vesting 25% RSU vesting schedule

Fourth-anniversary RSU vesting 25% RSU vesting schedule

Historical Context

5 past events · Latest: Jul 07 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 07	Strategic investment	Positive	+5.5%	Oberland Capital announced up to $400 million for genetic medicine development and commercialization.
May 14	Inducement equity grant	Negative	-5.5%	New chief development officer received options and RSUs under Nasdaq inducement rules.
May 14	First-quarter earnings	Neutral	-0.2%	Quarterly results included pipeline updates, financing details, revenue, cash, and net loss.
Apr 16	Public offering	Negative	-15.7%	Company priced 11,111,111 ordinary shares for approximately $100 million in gross proceeds.
Apr 16	Product acquisition	Negative	-15.7%	MeiraGTx agreed to acquire bota-vec with upfront payment, milestones, royalties, and filing plans.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The prior inducement-grant event was followed by a -5.53% 24-hour reaction, while the strategic investment was followed by a 5.54% gain; the five-event record was mixed.

Key Terms

nasdaq listing rule 5635(c)(4), non-qualified stock options, restricted stock units

3 terms

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4)."

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

non-qualified stock options financial

"non-qualified stock options to purchase 75,000 shares"

Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.

restricted stock units financial

"75,000 time-based restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON and NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced that the Compensation Committee of the Company’s Board of Directors approved equity awards under the Company’s 2026 Employment Inducement Award Plan to a new employee. The equity awards were granted as an inducement material to the new employee entering employment with MeiraGTx in accordance with Nasdaq Listing Rule 5635(c)(4).

The equity awards are comprised of (i) non-qualified stock options to purchase 75,000 shares of the Company’s ordinary shares with an exercise price per share equal to the closing price of an ordinary share on the Nasdaq Stock Market on the new employee’s start date, 25% of which will vest and become exercisable on the first anniversary of the new employee’s start date, with the remaining underlying shares vesting in 36 substantially equal installments each month thereafter, subject to the new employee’s continued employment with the Company through each applicable vesting date and (ii) 75,000 time-based restricted stock units (“RSUs”), with 50% of the RSUs vesting on the second anniversary of the new employee’s start date and 25% of the RSUs vesting on each of the third and fourth anniversaries of the new employee’s start date, subject to the new employee’s continued employment with the Company through each applicable vesting date.

About MeiraGTx

MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicines company with a broad pipeline with four late-stage clinical programs. Each of these programs uses local delivery of small doses, resulting in disease-modifying effects in both inherited and more common diseases, in the eye, Parkinson’s disease, and radiation-induced xerostomia. MeiraGTx uses its innovative technology in optimization of capsids, promoters, and novel translational control elements to develop best-in-class, potent, safe viral vectors. MeiraGTx’s broad pipeline is supported by end-to-end in-house manufacturing. MeiraGTx has built the most comprehensive manufacturing capabilities in the industry, including two that are licensed for GMP viral vector production and a GMP QC facility with clinical and commercial licensure. In addition, MeiraGTx has developed a proprietary manufacturing platform process over 9 years based on more than 20 different viral vectors with leading yield and quality aspects and commercial readiness. Uniquely, MeiraGTx has developed a novel technology for in vivo delivery of any biologic therapeutic using oral small molecules. This transformative riboswitch gene regulation technology allows precise, dose-responsive control of gene expression by oral small molecules. MeiraGTx is focusing the riboswitch platform on the regulated in vivo delivery of metabolic peptides, including GLP-1, GIP, Glucagon, Amylin, PYY, and Leptin, as well as cell therapy, CAR-T for liquid and solid tumors and autoimmune diseases, and additionally, PNS targets addressing long-term intractable pain. MeiraGTx has developed the technology to apply genetic medicine to common diseases, increasing efficacy, addressing novel targets, and expanding access in some of the largest disease areas where the unmet need remains high.

For more information, please visit www.meiragtx.com.

Contacts

Investors:
MeiraGTx
Investors@meiragtx.com 

or

Media:
Jordyn Temperato
LifeSci Communications
jtemperato@lifescicomms.com

FAQ

What inducement equity grant did MeiraGTx (MGTX) announce on August 6, 2026?

MeiraGTx announced an inducement equity grant to a new employee consisting of 75,000 stock options and 75,000 time-based RSUs. According to MeiraGTx, the awards were approved under its 2026 Employment Inducement Award Plan as a material inducement to join the company.

How do the MeiraGTx (MGTX) inducement stock options vest for the new employee?

The MeiraGTx inducement stock options vest 25% on the first anniversary of the employee’s start date, then monthly thereafter. According to MeiraGTx, the remaining 75% vest in 36 substantially equal monthly installments, subject to the employee’s continued employment with the company.

What is the vesting schedule for the 75,000 RSUs granted by MeiraGTx (MGTX)?

MeiraGTx’s 75,000 time-based RSUs vest 50% on the second anniversary of the employee’s start date, then 25% on each of the third and fourth anniversaries. According to MeiraGTx, all vesting is contingent on the employee’s continued employment through each vesting date.

How is the exercise price set for MeiraGTx (MGTX) inducement stock options?

The exercise price for MeiraGTx inducement stock options equals the closing price of an ordinary share on the employee’s start date. According to MeiraGTx, this pricing aligns the option value with the market value at the time employment begins.

Why did MeiraGTx (MGTX) use Nasdaq Listing Rule 5635(c)(4) for this equity award?

MeiraGTx used Nasdaq Listing Rule 5635(c)(4) because the equity awards were a material inducement for the new employee to join the company. According to MeiraGTx, the grant was made under its 2026 Employment Inducement Award Plan in compliance with this rule.